Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(3)

Detailed Status

Completed3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

completed3100%

Recent Activity

0 active trials
Showing 3 of 3
completed

Rapid Detection of COVID-19 by Portable and Connected Biosensor

NCT04367142
completed

Rapid Detection of COVID-19 by Portable and Connected Biosensor : Biological Proof of Concept

NCT04780334
completednot_applicable

Wearable Devices to Monitor Seizures in Autoimmune Epilepsy

NCT05627661

Clinical Trials (3)

Showing 3 of 3 trials
NCT04367142

Rapid Detection of COVID-19 by Portable and Connected Biosensor

Completed
NCT04780334

Rapid Detection of COVID-19 by Portable and Connected Biosensor : Biological Proof of Concept

Completed
NCT05627661Not Applicable

Wearable Devices to Monitor Seizures in Autoimmune Epilepsy

Completed

All 3 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
3